Perimeter Medical Imaging AI to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025

Core Insights - Perimeter Medical Imaging AI, Inc. will report its third quarter 2025 financial and operating results on November 12, 2025, followed by a webcast and conference call for discussion [1][2]. Company Overview - Perimeter Medical Imaging AI is a medical technology company based in Toronto and Dallas, focused on transforming cancer surgery through advanced imaging tools [3]. - The company offers the FDA-cleared Perimeter S-Series OCT system, which provides real-time, cross-sectional visualization of excised tissues at the cellular level [3]. - The investigational Perimeter B-Series OCT, featuring ImgAssist AI, is currently under evaluation in a pivotal clinical trial, supported by a grant of up to US$7.4 million from the Cancer Prevention and Research Institute of Texas [3]. Product Information - The Perimeter B-Series OCT is limited to investigational use in the U.S. and is not available for sale [4]. - The Perimeter S-Series OCT has received 510(k) clearance but has not been specifically evaluated for breast tissue or cancer applications [4].